Morpholino

MO1-olfm1a

ID
ZDB-MRPHLNO-081017-1
Name
MO1-olfm1a
Previous Names
  • Olfm1-MO (1)
Target
Sequence
5' - AGCAAAGGCACCGACATCTCTGCTC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-olfm1a
Phenotype
Phenotype resulting from MO1-olfm1a
Phenotype Fish Figures
axonogenesis disrupted, abnormal WT + MO1-olfm1a Fig. 7 from Nakaya et al., 2008
brain degenerate, abnormal WT + MO1-olfm1a text only from Nakaya et al., 2008
ciliary marginal zone damaged, abnormal WT + MO1-olfm1a Fig. 4 from Nakaya et al., 2008
cranial nerve II decreased thickness, abnormal WT + MO1-olfm1a Fig. 8 from Nakaya et al., 2012
cranial nerve II axon decreased amount, abnormal WT + MO1-olfm1a Fig. 7 from Nakaya et al., 2008
cranial nerve II axon decreased branchiness, abnormal WT + MO1-olfm1a Fig. 8 from Nakaya et al., 2012
cranial nerve II axon decreased length, abnormal WT + MO1-olfm1a Fig. 7 from Nakaya et al., 2008
cranial nerve II axon defasciculated, abnormal WT + MO1-olfm1a Fig. 7 from Nakaya et al., 2008
cranial nerve II axon arborization decreased occurrence, abnormal WT + MO1-olfm1a Fig. 8 from Nakaya et al., 2012
cranial nerve II axon extension decreased occurrence, abnormal WT + MO1-olfm1a Fig. 8 from Nakaya et al., 2012
eye decreased size, abnormal WT + MO1-olfm1a Fig. 4 from Nakaya et al., 2008
eye discolored, abnormal WT + MO1-olfm1a Fig. 4 from Nakaya et al., 2008
eye development delayed, abnormal WT + MO1-olfm1a text only from Nakaya et al., 2008
eye development disrupted, abnormal WT + MO1-olfm1a text only from Nakaya et al., 2008
head flat, abnormal WT + MO1-olfm1a text only from Nakaya et al., 2008
heart increased size, abnormal WT + MO1-olfm1a text only from Nakaya et al., 2008
hyosymplectic cartilage aplastic, abnormal WT + MO1-olfm1a Fig. 4 from Nakaya et al., 2008
integument rough, abnormal WT + MO1-olfm1a text only from Nakaya et al., 2008
lateral line nerve axon decreased length, abnormal WT + MO1-olfm1a Fig. 7 from Nakaya et al., 2008
mandibular arch skeleton aplastic, abnormal WT + MO1-olfm1a Fig. 4 from Nakaya et al., 2008
optic tectum decreased size, abnormal WT + MO1-olfm1a Fig. 7 from Nakaya et al., 2008
optic vesicle morphology, abnormal WT + MO1-olfm1a Fig. 8 from Nakaya et al., 2008
retina decreased size, abnormal WT + MO1-olfm1a Fig. 5 from Nakaya et al., 2008
retinal ganglion cell decreased amount, abnormal WT + MO1-olfm1a Fig. 5Fig. 6 from Nakaya et al., 2008
retinal ganglion cell nucleus apoptotic, abnormal WT + MO1-olfm1a Fig. 5 from Nakaya et al., 2008
retinal ganglion cell layer disorganized, abnormal WT + MO1-olfm1a Fig. 5Fig. 6 from Nakaya et al., 2008
retinal inner nuclear layer morphology, abnormal WT + MO1-olfm1a Fig. 6 from Nakaya et al., 2008
retinal inner nuclear layer cell degenerate, abnormal WT + MO1-olfm1a Fig. 5 from Nakaya et al., 2008
retinal inner nuclear layer nucleus apoptotic, abnormal WT + MO1-olfm1a Fig. 5 from Nakaya et al., 2008
retinal inner plexiform layer decreased thickness, abnormal WT + MO1-olfm1a Fig. 5 from Nakaya et al., 2008
retinal outer nuclear layer decreased thickness, abnormal WT + MO1-olfm1a Fig. 5 from Nakaya et al., 2008
retinal pigmented epithelium discolored, abnormal WT + MO1-olfm1a Fig. 5 from Nakaya et al., 2008
trunk deformed, abnormal WT + MO1-olfm1a text only from Nakaya et al., 2008
whole organism colorless, abnormal WT + MO1-olfm1a Fig. 4 from Nakaya et al., 2008
whole organism decreased length, abnormal WT + MO1-olfm1a Fig. 4 from Nakaya et al., 2008
Phenotype of all Fish created by or utilizing MO1-olfm1a
Phenotype Fish Conditions Figures
retinal inner nuclear layer nucleus apoptotic, abnormal WT + MO1-olfm1a standard conditions Fig. 5 from Nakaya et al., 2008
eye development disrupted, abnormal WT + MO1-olfm1a standard conditions text only from Nakaya et al., 2008
retina decreased size, abnormal WT + MO1-olfm1a standard conditions Fig. 5 from Nakaya et al., 2008
eye decreased size, abnormal WT + MO1-olfm1a standard conditions Fig. 4 from Nakaya et al., 2008
retinal pigmented epithelium discolored, abnormal WT + MO1-olfm1a standard conditions Fig. 5 from Nakaya et al., 2008
retinal inner nuclear layer cell degenerate, abnormal WT + MO1-olfm1a standard conditions Fig. 5 from Nakaya et al., 2008
cranial nerve II axon decreased amount, abnormal WT + MO1-olfm1a standard conditions Fig. 7 from Nakaya et al., 2008
cranial nerve II axon defasciculated, abnormal WT + MO1-olfm1a standard conditions Fig. 7 from Nakaya et al., 2008
head flat, abnormal WT + MO1-olfm1a standard conditions text only from Nakaya et al., 2008
retinal outer nuclear layer decreased thickness, abnormal WT + MO1-olfm1a standard conditions Fig. 5 from Nakaya et al., 2008
eye discolored, abnormal WT + MO1-olfm1a standard conditions Fig. 4 from Nakaya et al., 2008
axonogenesis disrupted, abnormal WT + MO1-olfm1a standard conditions Fig. 7 from Nakaya et al., 2008
cranial nerve II axon decreased branchiness, abnormal WT + MO1-olfm1a control Fig. 8 from Nakaya et al., 2012
hyosymplectic cartilage aplastic, abnormal WT + MO1-olfm1a standard conditions Fig. 4 from Nakaya et al., 2008
cranial nerve II axon arborization decreased occurrence, abnormal WT + MO1-olfm1a control Fig. 8 from Nakaya et al., 2012
optic vesicle morphology, abnormal WT + MO1-olfm1a standard conditions Fig. 8 from Nakaya et al., 2008
integument rough, abnormal WT + MO1-olfm1a standard conditions text only from Nakaya et al., 2008
cranial nerve II axon decreased length, abnormal WT + MO1-olfm1a standard conditions Fig. 7 from Nakaya et al., 2008
ciliary marginal zone damaged, abnormal WT + MO1-olfm1a standard conditions Fig. 4 from Nakaya et al., 2008
whole organism decreased length, abnormal WT + MO1-olfm1a standard conditions Fig. 4 from Nakaya et al., 2008
retinal ganglion cell decreased amount, abnormal WT + MO1-olfm1a standard conditions Fig. 5Fig. 6 from Nakaya et al., 2008
cranial nerve II axon extension decreased occurrence, abnormal WT + MO1-olfm1a control Fig. 8 from Nakaya et al., 2012
brain degenerate, abnormal WT + MO1-olfm1a standard conditions text only from Nakaya et al., 2008
lateral line nerve axon decreased length, abnormal WT + MO1-olfm1a standard conditions Fig. 7 from Nakaya et al., 2008
whole organism colorless, abnormal WT + MO1-olfm1a standard conditions Fig. 4 from Nakaya et al., 2008
retinal inner plexiform layer decreased thickness, abnormal WT + MO1-olfm1a standard conditions Fig. 5 from Nakaya et al., 2008
retinal ganglion cell layer disorganized, abnormal WT + MO1-olfm1a standard conditions Fig. 5Fig. 6 from Nakaya et al., 2008
cranial nerve II decreased thickness, abnormal WT + MO1-olfm1a control Fig. 8 from Nakaya et al., 2012
mandibular arch skeleton aplastic, abnormal WT + MO1-olfm1a standard conditions Fig. 4 from Nakaya et al., 2008
retinal ganglion cell nucleus apoptotic, abnormal WT + MO1-olfm1a standard conditions Fig. 5 from Nakaya et al., 2008
heart increased size, abnormal WT + MO1-olfm1a standard conditions text only from Nakaya et al., 2008
eye development delayed, abnormal WT + MO1-olfm1a standard conditions text only from Nakaya et al., 2008
optic tectum decreased size, abnormal WT + MO1-olfm1a standard conditions Fig. 7 from Nakaya et al., 2008
trunk deformed, abnormal WT + MO1-olfm1a standard conditions text only from Nakaya et al., 2008
retinal inner nuclear layer morphology, abnormal WT + MO1-olfm1a standard conditions Fig. 6 from Nakaya et al., 2008
Citations